(Q39417568)

11 September 2017

title

Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies (English)

1 reference

11 September 2017

Howden CW

1

1 reference

11 September 2017

Henning JM

2

1 reference

11 September 2017

Huang B

3

1 reference

11 September 2017

Lukasik N

4

1 reference

11 September 2017

Freston JW

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

The American Journal of Gastroenterology

11 September 2017

published in

1 reference

11 September 2017

volume

96

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1704-1710

1 reference

The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

Costs of acid-related disorders to a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03861.X

10.1111/J.1572-0241.2001.03861.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference